drugset / Trial / NCT03211143

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

NCT03211143

Phase 1 Completed 41 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverSingle-blindTreatment

Summary

A Study to compare Pharmacokinetics, Pharmacodynamics and safety of CKD-381 and D027 in healty subjects

Timeline

Start
2017-06-20
Primary completion
2017-08-28
Completion
2017-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-381 Unknown 20 mg
Subject Esomeprazole Small molecule 22.3 mg